This proposal is a competitive renewal application which main goal is to define the mechanisms by which ischemic preconditioning (IPC) promotes neuroprotection against cerebral ischemia. The main findings in the previous funding cycle were (a) the demonstration that epsilon protein kinase C (ePKC) plays a pivotal role in the induction of tolerance after ischemic preconditioning in brain (IPC) and (b) that resveratrol (3,5,4'- trihydroxystilbene) mimics cerebral ischemic preconditioning (IPC) via SIRT1. We show in preliminary studies that ischemic-, resveratrol- and 5PKC-induced preconditioning increase the expression of the neurotrophin brain-derived neurotrophic factor (BDNF). The main goals of the new funding cycle are to define the common signaling pathways activated by resveratrol and IPC that promote ischemic tolerance.
The specific aims and associated hypotheses include: 1) To define whether SIRT1 is necessary and sufficient in the induction of IPC neuroprotection. Since resveratrol may have multiple molecular targets, it is first important to define that its role in preconditioning requires activation of SIRT1;2) To determine the downstream signaling pathways that lead to SIRT1 mediated ischemic tolerance. Our preliminary evidence demonstrates that inhibition of the BDNF receptor (TrkB) abolishes neuroprotection in each of our preconditioning paradigms. Our main hypothesis here is that IPC/RPC increases BDNF levels via the SIRT1 pathway;3) Identification of synaptic targets and signaling pathways after preconditioning. Our hypothesis in this aim is that synaptic rearrangements underlie neuroprotection conferred by ischemic-, resveratrol (RPC)- and 5PKC (PPC)-induced preconditioning. An alternative hypothesis is that unlike IPC and PPC, RPC neuroprotection may not depend on synaptic modifications;instead the dominant effect of RPC involves direct activation of cell survival pathways;and 4) To determine whether ischemic tolerance can be induced by chronic resveratrol. The ultimate goal of this application is to provide some potential new therapies against cerebral ischemia. Our hypothesis is that chronic exposure to resveratrol results in a maintained preconditioned state similar to the single dose.

Public Health Relevance

Resveratrol is a naturally occurring compound found in red wine. Resveratrol confers neuroprotection against ischemia and is currently in clinical trials as an anti-cancer agent. These proposed experiments will lay the foundation for the development of resveratrol as a prophylactic neuroprotective agent against ischemia.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Neural Oxidative Metabolism and Death Study Section (NOMD)
Program Officer
Hicks, Ramona R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Schools of Medicine
Coral Gables
United States
Zip Code
Ding, Di; Enriquez-Algeciras, Mabel; Valdivia, Anddre Osmar et al. (2018) The Role of Deimination in Regenerative Reprogramming of Neurons. Mol Neurobiol :
Narayanan, Srinivasan V; Dave, Kunjan R; Perez-Pinzon, Miguel A (2018) Ischemic Preconditioning Protects Astrocytes against Oxygen Glucose Deprivation Via the Nuclear Erythroid 2-Related Factor 2 Pathway. Transl Stroke Res 9:99-109
Xu, Jing; Jackson, Charlie W; Khoury, Nathalie et al. (2018) Brain SIRT1 Mediates Metabolic Homeostasis and Neuroprotection. Front Endocrinol (Lausanne) 9:702
Jackson, Charles W; Escobar, Iris; Xu, Jing et al. (2018) Effects of ischemic preconditioning on mitochondrial and metabolic neruoprotection: 5' adenosine monophosphate-activated protein kinase and sirtuins. Brain Circ 4:54-61
Stradecki-Cohan, Holly M; Youbi, Mehdi; Cohan, Charles H et al. (2017) Physical Exercise Improves Cognitive Outcomes in 2 Models of Transient Cerebral Ischemia. Stroke 48:2306-2309
Cohan, Charles H; Stradecki-Cohan, Holly M; Morris-Blanco, Kahlilia C et al. (2017) Protein kinase C epsilon delays latency until anoxic depolarization through arc expression and GluR2 internalization. J Cereb Blood Flow Metab 37:3774-3788
Koronowski, Kevin B; Khoury, Nathalie; Saul, Isabel et al. (2017) Neuronal SIRT1 (Silent Information Regulator 2 Homologue 1) Regulates Glycolysis and Mediates Resveratrol-Induced Ischemic Tolerance. Stroke 48:3117-3125
Narayanan, Srinivasan V; Perez-Pinzon, Miguel A (2017) Ischemic preconditioning treatment of astrocytes transfers ischemic tolerance to neurons. Cond Med 1:2-8
Khoury, Nathalie; Koronowski, Kevin B; Perez-Pinzon, Miguel A (2016) Long-term window of ischemic tolerance: An evolutionarily conserved form of metabolic plasticity regulated by epigenetic modifications? J Neurol Neuromedicine 1:6-12
Morris-Blanco, Kahlilia C; Dave, Kunjan R; Saul, Isabel et al. (2016) Protein Kinase C Epsilon Promotes Cerebral Ischemic Tolerance Via Modulation of Mitochondrial Sirt5. Sci Rep 6:29790

Showing the most recent 10 out of 56 publications